NXGL, US65344E1073

NEXGEL stock: NEXGEL implements 1-for-20 reverse split affecting NEXGEL stock

Published on 10/23/2026 at 07:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter revenue reached USD 3.69 million, while GAAP loss was USD 3.61 million. NEXGEL stock had 487,384 shares after October 12, 2026.

Corporate actions and results

  • NEXGEL implemented a 1-for-20 reverse split on October 12, 2026.
  • Second-quarter revenue reached USD 3.69 million in the period ended June 30, 2026.
  • Shareholders approved the reverse-split proposal with 5,450,308 votes on September 23, 2026.
NXGL, US65344E1073, Illustration mit AI erstellt.

NEXGEL (ISIN US65344E1073) implemented a 1-for-20 reverse stock split on October 12, 2026, a move intended to support compliance with Nasdaq's USD 1.00 minimum bid requirement, according to NEXGEL. The company's second-quarter revenue reached USD 3.69 million for the period ended June 30, 2026, while consolidated net income was a loss of USD 3.61 million, according to Stock Observer.

Three decisions reshaped NXGL

On August 14, 2026, NEXGEL reported second-quarter revenue of USD 3.69 million, giving investors a fresh operating reference for the business, according to Stock Observer. On September 23, 2026, shareholders approved the reverse-split proposal by 5,450,308 votes to 747,210, as reported in the company's filing carried by StockTitan. On October 12, 2026, the 1-for-20 ratio took effect and reduced outstanding shares from 9,747,663 to approximately 487,384 before fractional-share adjustments, according to NEXGEL.

What does the split mean for compliance?

The reverse split changes the per-share calculation rather than the underlying business value. NEXGEL said the action was designed to lift its quoted share price above Nasdaq's USD 1.00 minimum bid threshold, but the company also stated that regaining or maintaining compliance was not guaranteed, according to StockTitan. That distinction matters because the split reduces the share count while leaving authorized share capital and the company's operating challenge separate from the mechanical price adjustment.

NXGL price and investor context

On Nasdaq, NXGL last stood at USD 4.76 on October 22, 2026 at 4:00 p.m. ET. The quote was 9.85 percent below the previous session's USD 5.28 close, while the latest quarterly figures showed revenue of USD 3.69 million and a USD 3.61 million net loss.

NEXGEL stock facts

  • Company: NEXGEL, Inc.
  • ISIN: US65344E1073
  • Ticker: NXGL
  • Primary exchange: Nasdaq Capital Market
  • Sector / Industry: Healthcare / Medical instruments and supplies

Market context: Market report S&P 500.

More news and analyses on NEXGEL stock

Disclaimer...
en | US65344E1073 | NXGL | boerse | 70396473 | bgmi